Stock Rich List
#766 on the corporate holders of 809 holders

Versant Venture Capital VI, L.P.

10% owner at Monte Rosa Therapeutics; 10% owner at LENZ Therapeutics; 10% owner at Tempest Therapeutics.

$57.2M
in disclosed stock, −$639K (−1.11%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
766th of 809
Companies held
3
Largest holding
GLUE, 88.1% of total
Latest SEC filing
Sep 18, 2025
Listed but not counted
$20.4M

What the $57.2M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Monte Rosa Therapeutics GLUE
Common Stock
Directly4,079,469$8.91$36.3M63.6%Form 4, Oct 28, 2024
Monte Rosa Therapeutics GLUE
Common Stock
Indirectly (see filing footnote)1,573,453$8.91$14.0M24.5%Form 4, Oct 29, 2024
LENZ Therapeutics LENZ
Common Stock
Directly1,183,543$3.34$4.0M6.9%Form 4, Sep 18, 2025
LENZ Therapeutics LENZ
Common Stock
Indirectly (see filing footnote)856,157$3.34$2.9M5.0%Form 4, Sep 18, 2025
Tempest Therapeutics TPST
Common Stock
Directly16,149
split-adjusted
$0.31$5K0.0%Form 4, Aug 12, 2024

Share counts are the amounts Versant Venture Capital VI, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Versant Venture Capital VI, L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Monte Rosa Therapeutics GLUE
Common Stock
Through Versant Vantage I, L.P.
Held by a company or fund the insider manages
1,589,053$8.91$14.2M—Form 4, Oct 29, 2024
LENZ Therapeutics LENZ
Common Stock
Through Versant Venture Capital VII, L.P.
Held by a company or fund the insider manages
876,437$3.34$2.9M—Form 4, Sep 18, 2025
LENZ Therapeutics LENZ
Common Stock
Through Versant Vantage II, L.P.
Held by a company or fund the insider manages
842,162$3.34$2.8M—Form 4, Sep 18, 2025
Monte Rosa Therapeutics GLUE
Common Stock
Indirectly (see filing footnote)
Held by a company or fund the insider manages
20,397$8.91$182K—Form 4, Oct 28, 2024
Monte Rosa Therapeutics GLUE
Common Stock
Indirectly (see filing footnote)
Held by an investment fund or partnership
17,595$8.91$157K—Form 4, Oct 28, 2024
Tempest Therapeutics TPST
Common Stock
Through Versant Vantage II, L.P.
Held by a company or fund the insider manages
162,973
split-adjusted
$0.31$50K—Form 4, Aug 8, 2024
Monte Rosa Therapeutics GLUE
Common Stock
Indirectly (see filing footnote)
Held by a company or fund the insider manages
5,499$8.91$49K—Form 4, Oct 28, 2024
Monte Rosa Therapeutics GLUE
Common Stock
Indirectly (see filing footnote)
Held by an investment fund or partnership
5,454$8.91$49K—Form 4, Oct 28, 2024
Tempest Therapeutics TPST
Common Stock
Through Versant Venture Capital IV, L.P.
Held by a company or fund the insider manages
90,084
split-adjusted
$0.31$28K—Form 4, Aug 8, 2024
Tempest Therapeutics TPST
Common Stock
Through Versant Side Fund IV, L.P.
Held by a company or fund the insider manages
567
split-adjusted
$0.31$174—Form 4, Aug 8, 2024

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
763CPIF Sparti SAF, L.P.
Director, Sonida Senior Living
$58.1M−$1.4M (−2.38%)
764Oaktree Acquisition Holdings III LS GP, Ltd.
10% owner, Oaktree Acquisition Corp. III Life Sciences
$57.8M+$54K (+0.09%)
765Petit Monts LLC
10% owner, American Drive Acquisition
$57.3M+$113K (+0.20%)
766Versant Venture Capital VI, L.P.
10% owner, Monte Rosa Therapeutics
$57.2M−$639K (−1.11%)
767AP IX College Holdings GP, LLC
10% owner, Taboola.com
$56.5M−$5.2M (−8.42%)
768College Parent Holdings GP, LLC
10% owner, Taboola.com
$56.2M−$5.2M (−8.42%)
769Pfizer INC
10% owner, ORIC Pharmaceuticals
$56.0M+$2.1M (+3.95%)

Other Monte Rosa Therapeutics insiders

All GLUE insiders

Questions

How much stock does Versant Venture Capital VI, L.P. own?

Versant Venture Capital VI, L.P. holds $57,185,073 in listed stock based on SEC filings and current prices, mostly Monte Rosa Therapeutics (GLUE). That ranks 766th on the Stock Rich List.

Is this Versant Venture Capital VI, L.P.'s net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.